Aims To investigate the radius of transmural (TM) ablation effect at the left atrial posterior wall (LAPW) during contact force (CF)-guided pulmonary vein isolation (PVI), using pure R unipolar electrogram (UE) morphology change -a histologically validated marker of radiofrequency (RF)-induced TM atrial ablation.
Introduction
The successful completion of electrical pulmonary vein isolation (PVI) for atrial fibrillation (AF) requires a permanent and transmural (TM) ablation lesion encirclement. 1, 2 To achieve this with contact force (CF)-guided radiofrequency (RF) technology, individual lesions must overlap, however excessive local RF delivery may result in life-threatening complications due to extra-cardiac thermal trauma. 3 Indeed, due to the close proximity of the oesophagus to the left atrial posterior wall (LAPW), inadvertent oesophageal thermal injury may be seen in up to 48% patients. 4 Despite considerable research efforts to identify suitable RF targets, recent reports of an increase in the rate of atrio-oesophageal fistula following the introduction of CF-sensing catheters 5, 6 indicates a possible causative relationship, and highlights the risks of conducting PVI with an imperfect understanding of when TM ablation has been achieved.
Clearly, development of accurate means to assess the occurrence and radius of TM ablative effect is desirable towards achieving "tailored" RF delivery protocols, and should represent an important advance towards improving the safety and efficacy of CF-guided PVI.
Promising recent research has demonstrated greater PVI procedural success using the VISITAG™ Module and ablation index (AI) -an approach with theoretically greater merit in view of the objective RF annotation processes and the incorporation of RF power into the derived ablation targets. 7 However, this research is not without methodological concerns: (1) During the AI target protocol derivation phase 8 , CF-guided RF ablation was performed employing end-points lacking suitable scientific validation -i.e. bipolar electrogram (BE) abatement of 80% 9 and RF duration 20-40s. 8, 10 Importantly, a recent report into the utility of near field ultrasound (NFUS) to assess the real-time development of lesion transmurality in canines demonstrated atrial TM RF effect with only 43% BE attenuation (25-30W, 5ml/min), and NFUS illustration of TM effect during LA RF application within 14s. 11 Furthermore, 6 during PVI employing LAPW ablation at 25W (CF 10-20g force-over-time 100% minimum 1g). 15 This approach was derived using observations of annotated RF delivery according to the occurrence of intra-procedural recovery of pulmonary vein (PV) conduction; i.e. without reference to electrogram-based tissue response data.
However, a subsequent canine study using CF-guided power-controlled irrigated RF at 30W demonstrated the potential utility of real-time pure R unipolar electrogram (UE) morphology change towards the attainment of "tailored" RF; histologically validated TM atrial ablation 7 was achieved in 95% of lesions terminated at the first occurrence of pure R UE, with time to pure R UE, ~7s and mean lesion depth 4.3mm. Furthermore, while increasing the RF duration to pure R + 5s resulted in histologically TM ablation in 100% without extra-cardiac thermal trauma, lesions terminated at pure R + 10s, +20s and "conventional" 30s total RF, although resulting in 100% pure R UE morphology and histologically proven TM ablation, had 11-17% occurrence of extra-cardiac thermal trauma. 16 Subsequently, the release of CARTOREPLAY™ (Biosense Webster) permitted assessment of UE morphology change following PVI employing this previously derived CF and VISITAG™-guided PVI protocol. These investigations demonstrated significantly shorter time to pure R UE morphology change at left-sided first-annotated LAPW sites (4.9s v 6.7s; p=0.02), associated with significantly greater impedance drop, compared to right-sided sites.
These findings were explained neither by differences in RF duration (~15s) nor maximum catheter tip distance moved, and occurred despite significantly greater mean contact force (CF) at right-sided sites. 13 However, when aiming for ≤ 6mm inter-ablation site distance during continuous RF application, "per protocol" subsequently annotated sites required minimum target RF duration of ~9s. 15 Therefore, the purpose of this present report was to retrospectively investigate the onset timing of TM UE morphology change at secondannotated LAPW sites according to the distance from site 1, thereby aiming to identify the radius of TM ablation effect resulting from this previously developed approach to PVI.
Methods
Retrospective analysis of VISITAG™ Module and CARTOREPLAY™ data was performed at first and second-annotated LAPW ablation sites following single-operator PVI, for the same previously reported consecutive group of unselected patients with symptomatic AF undergoing PVI according to current treatment indications 3 and as previously descrtibed. We calculated the catheter tip (position) SD and maximum displacement (from the mean position) at each annotated site from exported VISITAG™ Module data using R 3.3.3. 17 The RF duration, mean CF, force time integral (FTI) and impedance drop for each annotated site was obtained from exported VISITAG™ Module data; inter-ablation site distance was obtained using the proprietary measurement tool. Retrospective UE analysis was performed 9 as previously described, with the time to pure R UE morphology change taken at the first of 3 consecutively occurring pure R complexes, no more than 1 of which could be an atrial ectopic. 13 All procedures were performed during proximal pole CS pacing at 600ms. To eliminate possible error in the assessment of the timing of pure R UE morphology change onset at second-annotated sites due to "non-annotated" RF delivery (i.e. >2mm positional stability and/or 0g CF events), subsequent analyses excluded all inter-ablation site transitions with >17ms interval (i.e. reflecting the minimum VISITAG™ Module system timing interval). The one instance of failure to achieve pure R UE morphology change at annotated site 1 and one instance at a second-annotated site were also excluded, leaving 30 pairs of first and second-annotated sites (18 left and 12 right-sided); data are shown in table 1.
RF duration at first-annotated LAPW sites was significantly greater than at second-annotated sites, as per the ablation protocol. CF was without significant difference, but FTI was significantly greater at site 1 (i.e. secondary to the greater protocol RF duration). Similarly, impedance drop was significantly greater at site 1, but importantly there was a significantly greater impedance drop at each left-sided site, explained neither on the basis of differences in RF duration, CF, nor measures of ablation catheter positional stability. Indeed, for both catheter position SD and maximum distance moved, left-sided annotated sites demonstrated significantly greater measures of catheter position instability. Notably, the time to pure R UE morphology change was significantly shorter at second-annotated sites (p<0.001).
Furthermore, pure R UE morphology was present at second-annotated site onset in 13 of 18 (72%) left-sided and 9 of 12 (75%) right-sided sites (figure 2); overall 22/30 (73% 
Discussion
This study presents a description of novel methodology permitting the in vivo assessment of the radius of RF-induced thermal effects during PVI, utilising VISITAG™ Module objective ablation site annotation and CARTOREPLAY™. Pure R UE morphology change -a histologically validated marker of TM atrial ablation 16, 18 -was analysed at first and secondannotated sites of RF delivery during LAPW ablation employing continuous RF delivery.
Together with measured inter-ablation site distances, these data identified a radius of thermal injury up to 7mm from annotated site 1 (figure 2); 73% second-annotated sites demonstrated immediate TM UE morphology change, with the time to pure R UE morphology change significantly shorter overall. Furthermore, the demonstration of acutely durable PVI resulting from significantly shorter "per protocol" RF delivery at second-annotated sites, indicates that when PVI is performed in the manner described, continuous RF delivery is likely to represent a more efficient approach towards TM linear lesion creation than point-by-point (PbP) RF application. This hypothesis is supported by findings from an ex vivo bovine myocardial model of linear ablation, where compared to PbP ablation, significantly greater lesion volumes resulted from continuous RF application despite equivalent energy delivery. These findings were explained on the basis of continuous RF not permitting the passive convective cooling that may be apparent between interrupted RF applications. 19 A subsequent in vivo magnetic resonance imaging (MRI) thermography study undertaken during canine LV RF application demonstrated an expanding thermal lesion as power was increased. 20 Extrapolating these data to the left atrium during PVI, it may be postulated that the small 12 catheter tip movements during VISITAG™ Module guidance in our study resulted in new ablation site annotation, yet remained within a zone of thermal injury secondary to RF application at site 1. Theoretically, durable RF effect at such second-annotated sites could be achieved using significantly shorter RF delivery considering the higher starting tissue temperature, evidenced by the immediately apparent UE morphology change. This finding is clearly of great clinical relevance in view of the common practice of continuous RF delivery during RF, yet with presently no adjustment towards RF delivery at consecutive sites suggested in CF-guided PVI "guideline recommendations". 21, 22 Indeed, an awareness of these novel findings may facilitate a reduction in RF delivery without compromising procedural efficacy, while potentially helping to reduce the risk of extra-cardiac thermal trauma.
This present report also confirms the previous finding of greater RF energy effect at left-sided LAPW sites in vivo, and extends this to second-annotated sites during continuous RF application. This cannot be explained by differences in measured RF delivery (RF duration, CF, power), and perhaps counter-intuitively was noted despite significantly greater measured ablation catheter positional instability at left-sided sites. Compared to first-annotated sites, there was also greater positional instability at all second-annotated sites; however, this can be explained by the fact that second-annotated sites by definition included one deliberate catheter tip acceleration / deceleration event (i.e. at "annotation start") and another acceleration event (i.e. at "annotation end"), whereas at site 1 there was only one deliberate catheter acceleration event at "annotation end". The mechanisms underlying greater left-sided LAPW RF energy effect remain unknown, but logically must represent either significantly greater surface area of ablation catheter tip-tissue interaction (and consequent greater energy delivery 23 ), and/or less out-of-phase catheter-tissue motion, during left-sided LAPW RF delivery. 13 Finally, these present data represent electrogram-based evidence supporting the previously employed methodology resulting in the development of a CF and VISITAG™ Moduleguided approach to PVI, using continuous RF application. 15 When combined with the methods for UE morphology assessment described in this present report and taken alongside our suggestion that through the adoption of suitable stability filters, the VISITAG™ Module provides a "language" with which to describe the RF "effector arm" 13 , this approach represents a new methodological platform for in vivo RF ablation research in human subjects.
Furthermore, given the theoretical universal applicability of such VISITAG™ Module-based analyses, these methods could also be employed during investigations using animal models of CF-guided RF ablation; e.g. investigating the acute tissue response following very short duration, high power delivery. Using this approach and when combined with histologically validated TM tissue RF effects, VISITAG™ Module-based measures of RF delivery and ablation catheter stability of greater scientific validity could be identified and applied in future clinical studies of human subjects.
Study limitations
This present report is of a single-operator's practice, utilising GA (with IPPV) in all.
Therefore, the described approach to ablation is not a direct recommendation for others to follow without careful consideration. Indeed, in view of the very short second-annotated site time to pure R UE morphology change demonstrated, yet "per protocol" annotated site 2 RF duration of ~9s, some LAPW lesions were probably accompanied by inadvertent extracardiac thermal trauma. Accordingly, it may be possible to achieve durable PVI at lower risk of extra-cardiac thermal trauma through employing even shorter RF duration (and possibly also lower RF power) than reported here; this clearly requires further study. Also, this report is limited to the first two annotated LAPW sites -chosen as this represented the simplest methodology to permit a description of RF-induced changes at immediately adjacent, ablation 14 naive sites. A description of UE morphology change at all VISITAG™ Module-annotated sites during CF-guided PVI would be extremely useful, but is a more complex undertaking and was beyond the scope of this present report. However, these data have already been collected for this same patient cohort and will form the basis of a future report.
Previous single-centre research conducted before the advent of CF sensing demonstrated the potentially reversible nature of pure R UE morphology change at sites of intra-procedural recovery of PV conduction. 24 Findings from a study of superfused guinea pig papillary muscle responses to thermal insult may provide insights into this finding; i.e. temperaturedependent depolarisation displayed a sigmoidal response, with loss of excitability at >42. an inter-ablation site distance ≥ 6mm was associated with adjacent annotated RF duration of 3.0s. 15 Although representing an important caveat towards the interpretation of pure R UE morphology change in vivo, particularly when this present report was without histological examination of sites of RF delivery, there were no instances of intra-procedural recovery of conduction following RF protocol completion. Furthermore, in view of the second-annotated site "per protocol" RF duration of ~9s, yet with near instantaneous pure R UE morphology change evident, most second-site RF applications were to at least that duration employed by
Bortone et al when achieving single-site 100% histologically-confirmed TM lesions of 4.3mm depth. 16 Although it is scientifically invalid to draw firm conclusions from such comparisons (particularly when VISITAG™ Module annotation was not employed during these animal studies), together with the previously reported high procedural efficacy of this present CF and VISITAG™ Module-guided protocol 15 , it is very unlikely that RF application at these LAPW sites resulted in non-TM lesions. 15 All UE morphology data were collected retrospectively, so this report does not prove that modification of RF delivery based on real-time UE morphological assessment during VISITAG™ Module and CF-guided PVI is appropriate. Indeed, taken together with the finding of pure R UE morphology change reversibility during non-CF guided PVI 24 , reliance on this factor alone is probably inappropriate. Instead, a more suitable approach may utilise real-time UE morphology change and other measures of energy delivery and/or tissue response (i.e. RF duration, impedance drop) at objectively annotated sites. Obviously, this remains to be proven but is worthy of further research, not least since this may result in the development of "tailored" and possibly safer, RF PVI ablation protocols.
When considering the methodology for timing of pure R UE morphology change onset utilised in this present report, there was possible error introduced according to the chosen base atrial pacing rate. For example and taking the worst possible scenario, the first paced atrial electrogram demonstrating pure R morphology change may have occurred 600ms after second-annotated site onset, yet for simplicity and to avoid far more time-consuming measurements, for reporting purposes this was classified as 0s. However, this should not seriously undermine the overall findings of this present report, since it is highly unlikely that all these intervals were 600ms. Furthermore, even if they were, re-classifying all "0s events" to 600ms would still represent a significantly shorter time to pure R UE morphology change at second-annotated sites.
Finally, the ability of VISITAG™ Module-based RF annotation to function as a "language"
for the RF "effector arm" in vivo for both research and clinical practice, as suggested, remains to be proven. However, this is an important area for future investigations since without such facility there is no suitable means to standardise and report approaches to RF delivery during future randomised controlled trials, making the task of translating any useful findings into clinical practice, impossible. 
